Component

Human carcinoma-cell agmatine uptake

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Agmatine uptake was abrogated in a polyamine-transport-deficient human carcinoma cell line.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Human transport-deficient carcinoma cells compared with transport-capable cells.
    limitations
    Not an inherited human deficiency syndrome or proof of nutrient depletion.
    nutrient_topic
    Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
    plain_language
    An extracellular supply cannot compensate for absent entry in this model.
    primary_references
    Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 68–74

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transport-deficient carcinoma cells compared with transport-capable cells. · source_derived_draft · unverified_draft

    ## agmatine-sulfate-carrier-loss An extracellular supply cannot compensate for absent entry in this model. Agmatine uptake was abrogated in a polyamine-transport-deficient human carcinoma cell line. Model: Human transport-deficient carcinoma cells compared with transport-capable cells. Limitations: Not an inherited human deficiency syndrome or proof of nutrient depletion. Evidence access: Primary abstract Polyamine transport system mediates agmatine transport in mammalian cells. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11401856/ · DOI 10.1152/ajpcell.2001.281.1.C329
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards